ATG-Thymoglobulin Versus ATG-Fresenius for Conditioning in Thalassemia Patients Who Underwent Allogenic Stem Cell Transplantation from Matched-Sibling Donor: A Tertiary Cancer Care Center Short-Term Experience-Reference-Cited by-同舟云学术

ATG-Thymoglobulin Versus ATG-Fresenius for Conditioning in Thalassemia Patients Who Underwent Allogenic Stem Cell Transplantation from Matched-Sibling Donor: A Tertiary Cancer Care Center Short-Term Experience

Published:2024-09-05 Issue: Volume: Page:1-6
ISSN:0363-0269
Container-title:Hemoglobin
language:en
Short-container-title:Hemoglobin

Author:

Singh Reema¹,Halder Rohan¹^ORCID,Hemant Gupta Vinayak¹,Rainchwar Sujay¹,Bhatia Niharika¹,Mishra Varsha¹,Panda Tribikram¹,Patra Pritish Chandra¹^ORCID,Agrawal Narendra¹,Bhurani Dinesh¹

Affiliation:

1. Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03630269.2024.2398244

Reference16 articles.

1. Global epidemiology of haemoglobin disorders and derived service indicators

2. Regional desk review of haemoglobinopathies with an emphasis on thalassemia and accessibility and availability of safe blood and blood products as per these patients’ requirement in South-East Asia under universal health coverage. New Delhi: World Health Organization Regional Office for South-East Asia; 2021. Licence: CC BY-NC-SA 3.0 IGO [cited 2023 May 9]. Available from: https://www.who.int/publications/i/item/9789290228516.

3. Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000–2010

5. Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years